A New Binding Assay of von Willebrand Factor and Glycoprotein Ib Using Solid-Phase Biotinylated Platelets

To obtain compounds that inhibit the interaction of von Willebrand factor (vWF) and glycoprotein (GP) Ib, a novel binding assay was established. The binding of fixed platelets to vWF-R497 mutant was quantified by a solid phase assay. In this assay, fixed platelets bound to the vWF-R497 mutant, carry...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenji Hayata (Author), Takayuki Nakayama (Author), Tadashi Matsushita (Author), Katsuichi Sakano (Author)
Format: Book
Published: Elsevier, 2008-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4c8eeaf2c73941a7aa60b40bfd34a39f
042 |a dc 
100 1 0 |a Kenji Hayata  |e author 
700 1 0 |a Takayuki Nakayama  |e author 
700 1 0 |a Tadashi Matsushita  |e author 
700 1 0 |a Katsuichi Sakano  |e author 
245 0 0 |a A New Binding Assay of von Willebrand Factor and Glycoprotein Ib Using Solid-Phase Biotinylated Platelets 
260 |b Elsevier,   |c 2008-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.08147SC 
520 |a To obtain compounds that inhibit the interaction of von Willebrand factor (vWF) and glycoprotein (GP) Ib, a novel binding assay was established. The binding of fixed platelets to vWF-R497 mutant was quantified by a solid phase assay. In this assay, fixed platelets bound to the vWF-R497 mutant, carrying the deletion of Glu497-Tyr508 and the missense mutation of Arg545 to Ala, without binding modulators such as ristocetin. The Kd value of the binding was 2.8 nM, which was consistent with the result from liquid binding assay. The binding was inhibited by aurin tricarboxylic acid (ATA) and an anti GPIb antibody, AK2. Using this binding assay, we screened our library compounds and obtained D74-3736. This compound also inhibited ristocetin-induced platelet aggregation in the human platelet-rich plasma. Keywords:: biotinylation of fixed platelets, binding assay of von Willebrand factor (vWF) to glycoprotein Ib (GPIb) 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 108, Iss 2, Pp 217-221 (2008) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319313581 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/4c8eeaf2c73941a7aa60b40bfd34a39f  |z Connect to this object online.